The current study revealed that the 17 Fuzi target genes are closely related to AD and maybe the key for Fuzi anti-AD process, especially GRIN1 and MAPK1. The 17 genes are significantly differentially expressed between AD and normal samples (RMS_p ≤ 0.05). The gene discussed is MAPK1; the disease is Alzheimer disease.